vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $333.4M, roughly 1.1× PRA GROUP INC). PRA GROUP INC runs the higher net margin — 17.0% vs -0.8%, a 17.7% gap on every dollar of revenue. On growth, PRA GROUP INC posted the faster year-over-year revenue change (13.7% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-90.4M). Over the past eight quarters, PRA GROUP INC's revenue compounded faster (14.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.
ASIX vs PRAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $333.4M |
| Net Profit | $-2.8M | $56.5M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 37.7% |
| Net Margin | -0.8% | 17.0% |
| Revenue YoY | 9.4% | 13.7% |
| Net Profit YoY | -892.9% | 206.3% |
| EPS (diluted) | $-0.11 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $333.4M | ||
| Q3 25 | $374.5M | $311.1M | ||
| Q2 25 | $410.0M | $287.7M | ||
| Q1 25 | $377.8M | $269.6M | ||
| Q4 24 | $329.1M | $293.2M | ||
| Q3 24 | $398.2M | $281.5M | ||
| Q2 24 | $453.5M | $284.2M | ||
| Q1 24 | $336.8M | $255.6M |
| Q4 25 | $-2.8M | $56.5M | ||
| Q3 25 | $-2.6M | $-407.7M | ||
| Q2 25 | $31.4M | $42.4M | ||
| Q1 25 | $23.3M | $3.7M | ||
| Q4 24 | $352.0K | $18.5M | ||
| Q3 24 | $22.3M | $27.2M | ||
| Q2 24 | $38.9M | $21.5M | ||
| Q1 24 | $-17.4M | $3.5M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 37.7% | ||
| Q3 25 | -0.9% | -101.4% | ||
| Q2 25 | 7.7% | 29.6% | ||
| Q1 25 | 7.7% | 27.7% | ||
| Q4 24 | -3.9% | 32.1% | ||
| Q3 24 | 7.5% | 32.0% | ||
| Q2 24 | 11.5% | 31.4% | ||
| Q1 24 | -7.0% | 26.0% |
| Q4 25 | -0.8% | 17.0% | ||
| Q3 25 | -0.7% | -131.0% | ||
| Q2 25 | 7.7% | 14.7% | ||
| Q1 25 | 6.2% | 1.4% | ||
| Q4 24 | 0.1% | 6.3% | ||
| Q3 24 | 5.6% | 9.6% | ||
| Q2 24 | 8.6% | 7.6% | ||
| Q1 24 | -5.2% | 1.4% |
| Q4 25 | $-0.11 | $1.47 | ||
| Q3 25 | $-0.10 | $-10.43 | ||
| Q2 25 | $1.15 | $1.08 | ||
| Q1 25 | $0.86 | $0.09 | ||
| Q4 24 | $0.02 | $0.47 | ||
| Q3 24 | $0.82 | $0.69 | ||
| Q2 24 | $1.43 | $0.54 | ||
| Q1 24 | $-0.65 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $104.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $979.9M |
| Total Assets | $1.7B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $104.4M | ||
| Q3 25 | $23.7M | $107.5M | ||
| Q2 25 | $18.4M | $131.6M | ||
| Q1 25 | $8.3M | $128.7M | ||
| Q4 24 | $19.6M | $105.9M | ||
| Q3 24 | $17.3M | $141.1M | ||
| Q2 24 | $12.1M | $118.9M | ||
| Q1 24 | $20.6M | $108.1M |
| Q4 25 | $815.2M | $979.9M | ||
| Q3 25 | $818.2M | $928.5M | ||
| Q2 25 | $823.7M | $1.3B | ||
| Q1 25 | $794.4M | $1.2B | ||
| Q4 24 | $774.6M | $1.1B | ||
| Q3 24 | $766.4M | $1.2B | ||
| Q2 24 | $746.6M | $1.1B | ||
| Q1 24 | $713.2M | $1.1B |
| Q4 25 | $1.7B | $5.1B | ||
| Q3 25 | $1.7B | $5.0B | ||
| Q2 25 | $1.6B | $5.4B | ||
| Q1 25 | $1.6B | $5.1B | ||
| Q4 24 | $1.6B | $4.9B | ||
| Q3 24 | $1.5B | $4.9B | ||
| Q2 24 | $1.5B | $4.7B | ||
| Q1 24 | $1.5B | $4.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $-85.5M |
| Free Cash FlowOCF − Capex | $36.1M | $-90.4M |
| FCF MarginFCF / Revenue | 10.0% | -27.1% |
| Capex IntensityCapex / Revenue | 7.7% | 1.4% |
| Cash ConversionOCF / Net Profit | — | -1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-169.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $-85.5M | ||
| Q3 25 | $26.6M | $-10.1M | ||
| Q2 25 | $21.1M | $-12.9M | ||
| Q1 25 | $11.4M | $-52.6M | ||
| Q4 24 | $64.2M | $-94.6M | ||
| Q3 24 | $57.3M | $-35.0M | ||
| Q2 24 | $50.2M | $-29.5M | ||
| Q1 24 | $-36.2M | $-73.0M |
| Q4 25 | $36.1M | $-90.4M | ||
| Q3 25 | $66.0K | $-11.3M | ||
| Q2 25 | $-7.2M | $-14.2M | ||
| Q1 25 | $-22.6M | $-53.5M | ||
| Q4 24 | $29.8M | $-98.6M | ||
| Q3 24 | $26.8M | $-36.1M | ||
| Q2 24 | $16.7M | $-30.8M | ||
| Q1 24 | $-71.6M | $-73.5M |
| Q4 25 | 10.0% | -27.1% | ||
| Q3 25 | 0.0% | -3.6% | ||
| Q2 25 | -1.7% | -4.9% | ||
| Q1 25 | -6.0% | -19.8% | ||
| Q4 24 | 9.1% | -33.6% | ||
| Q3 24 | 6.7% | -12.8% | ||
| Q2 24 | 3.7% | -10.8% | ||
| Q1 24 | -21.3% | -28.8% |
| Q4 25 | 7.7% | 1.4% | ||
| Q3 25 | 7.1% | 0.4% | ||
| Q2 25 | 6.9% | 0.4% | ||
| Q1 25 | 9.0% | 0.3% | ||
| Q4 24 | 10.4% | 1.4% | ||
| Q3 24 | 7.7% | 0.4% | ||
| Q2 24 | 7.4% | 0.5% | ||
| Q1 24 | 10.5% | 0.2% |
| Q4 25 | — | -1.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | -0.30× | ||
| Q1 25 | 0.49× | -14.37× | ||
| Q4 24 | 182.29× | -5.13× | ||
| Q3 24 | 2.57× | -1.29× | ||
| Q2 24 | 1.29× | -1.37× | ||
| Q1 24 | — | -21.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
PRAA
| GB | $170.1M | 51% |
| Other | $163.3M | 49% |
